Sifted Studio

✓

مطالبة

As general AI models become increasingly commoditised, the ultimate advantage now lies in industry-specific data and local market execution.In this podcast, Sifted's associate editor Freya Pratty is joined by Lexroom CEO and cofounder Paolo Fois to unpack how he built one of Europe’s fastest-g…

Europe’s AI opportunity is a new podcast mini-series brought to you by Sifted and Nebius, an AI infrastructure company building full-stack cloud for the AI era.  In this episode, Sifted’s Europe Editor Mimi Billing will be exploring what the next phase of Europe’s AI growth will look like. This epi…

Europe’s AI opportunity is a new podcast mini-series brought to you by Sifted and Nebius, an AI infrastructure company building full-stack cloud for the AI era.  Over the next three episodes, Sifted’s senior reporter Daphné Leprince-Ringuet will be exploring the potential of AI for Europe’s enterpr…

Europe's AI opportunity is a new podcast mini-series is brought to you by Sifted and Nebius, an AI infrastructure company building full-stack cloud for the AI era. Over the next three episodes, Sifted's senior reporter Daphné Leprince-Ringuet will be exploring the potential of AI for Euro…

We discussed the most effective ways to measure and communicate trust in AI systems, how existing frameworks can help validate new AI systems and how the technology poses new questions for mitigating risk.  Participating in the discussion were:  Song Hwee Chia, deputy CEO of Temasek, a global inve…

Europe's AI opportunity is a new podcast mini-series is brought to you by Sifted and Nebius, an AI infrastructure company building full-stack cloud for the AI era.  Over the next three episodes, Sifted's senior reporter Daphné Leprince-Ringuet will be exploring the potential of AI for Eur…

Drug discovery and development is an arduous, expensive process that usually results in failure. An estimated 90% of clinical drugs don’t make it to market, after an R&D process that can take as long as 15 years, and cost up to $2bn.  With AI, those numbers could be dramatically improved. Drug …

Every week, startup life reporter Anisah Osman Britton will be sitting down with resilient founders and expert investors to discuss operating in a downturn. From what we can learn from previous financial crises to the anatomy of mergers and acquisitions, we'll be getting top tips on how to sur…

Every week, startup life reporter Anisah Osman Britton will be sitting down with resilient founders and expert investors to discuss operating in a downturn. From what we can learn from previous financial crises to the anatomy of mergers and acquisitions, we'll be getting top tips on how to sur…